| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |